Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04335682
Title Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide
Acronym ARACOG
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.